ACI’s 11th Annual Paragraph IV Disputes Conference

The American Conference Institute’s (“ACI’s”) 11th annual “Paragraph IV Disputes” conference is right around the corner! The conference will take place from April 24-26, 2017 at the Conrad New York in New York, NY. 

ACI has put together an excellent program for conference attendees that includes presentations from esteemed Judges and key representatives from the FDA, PTO, and the FTC. In addtion, attendees will get to hear from a virtual “who’s who” of Hatch-Waxman litigators and industry decision makers.  Hyman, Phelps & McNamara, P.C.’s Kurt R. Karst, along with Maryll W. Toufanian, Deputy Director of the Office of Generic Drug Policy, FDA, and Margaret J. Sampson, a Partner at Baker Botts L.L.P., will be speaking at a Q&A session on FDA’s October 2016 final rule implementing certain portions of the December 2003 Medicare Modernization Act (see our previous post here).

FDA Law Blog is a conference media partner. As such, we can offer our readers a special discount off the current price tier.  The discount code is: P10-999-FDAB17.  You can access the conference brochure and sign up for the event here.

 We look forward to seeing you at the conference.